Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Kezar Life Sciences Q2 EPS $(0.25) Down From $(0.22) YoY

Kezar Life Sciences (NASDAQ:KZR) reported quarterly losses of $(0.25) per share. This is a 13.64 percent decrease over losses of $(0.22) per share from the same period last year.
byBenzinga Newsdesk
August 12, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

Kezar Life Sciences (NASDAQ:KZR) reported quarterly losses of $(0.25) per share. This is a 13.64 percent decrease over losses of $(0.22) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts